NewGenIvf Corp - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NIVF

NewGenIvf Group (NIVF) is actively expanding its network of infertility clinics across Southeast Asia by implementing advanced reproductive methodologies. High barriers to entry are driven by strict licensing requirements and significant infrastructure costs. This chart on GURU.Markets shows that the EV/EBITDA multiple stands at 0.00, confirming the moderate cyclicality of the business, as expensive IVF procedures often depend on the economic climate.

When screening for issuer reliability, it is essential to compare the enterprise value (EV) with its earnings before interest, taxes, depreciation, and amortization (EBITDA). This ratio determines the asset payback period, accounting for debt load and the actual capacity to generate cash flow. Tracking the EV/EBITDA valuation of NewGenIvf Group Limited (NIVF) over time reveals how effectively the company optimizes costs for outsourced logistics and clinic IT support.